Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Kidney Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 177 articles:
HTML format



Single Articles


    January 2022
  1. ESKANDARY F, Bohmig GA
    ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
    Transpl Int. 2022;36:10281.
    PubMed    


  2. DE SANDES-FREITAS TV, Cristelli MP, Requiao-Moura LR, Modelli de Andrade LG, et al
    Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study.
    Transpl Int. 2022;36:10205.
    PubMed     Abstract available


  3. LIM WH, Ooi E, Pilmore HL, Johnson DW, et al
    Interactions Between Donor Age and 12-Month Estimated Glomerular Filtration Rate on Allograft and Patient Outcomes After Kidney Transplantation.
    Transpl Int. 2022;36:10199.
    PubMed     Abstract available


  4. PRONK MC, Burnapp L, Reinders MEJ, Massey EK, et al
    Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors.
    Transpl Int. 2022;36:10091.
    PubMed     Abstract available


  5. WANG Y, Veltkamp DMJ, van der Boog PJM, Hemmelder MH, et al
    Illness Perceptions and Medication Nonadherence to Immunosuppressants After Successful Kidney Transplantation: A Cross-Sectional Study.
    Transpl Int. 2022;36:10073.
    PubMed     Abstract available


  6. CHANG A, Schaubel DE, Chen M, Abt PL, et al
    Trends and Outcomes of Hypothermic Machine Perfusion Preservation of Kidney Allografts in Simultaneous Liver and Kidney Transplantation in the United States.
    Transpl Int. 2022;35:10345.
    PubMed     Abstract available


  7. SCHIMPF J, Davidovic T, Abbassi-Nik A, Sprenger-Mahr H, et al
    Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.
    Transpl Int. 2022;36:10357.
    PubMed    


  8. CHALKLIN CG, Koimtzis G, Khalid U, Carrington-Windo E, et al
    SARS-CoV-2 Infection Can Lead to an Increase in Tacrolimus Levels in Renal Transplant Patients: A Cohort Study.
    Transpl Int. 2022;35:10127.
    PubMed     Abstract available


  9. HOD T, Ben-David A, Olmer L, Scott N, et al
    BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients.
    Transpl Int. 2022;35:10239.
    PubMed     Abstract available


  10. KROGSTAD V, Elgstoen KBP, Johnsen LF, Hartmann A, et al
    High Plasma Oxalate Levels Early After Kidney Transplantation Are Associated With Impaired Long-Term Outcomes.
    Transpl Int. 2022;35:10240.
    PubMed     Abstract available


  11. SHARMA A, Jorgensen DR, Mehta RB, Sood P, et al
    The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients.
    Transpl Int. 2022;35:10094.
    PubMed     Abstract available


  12. RANA MAGAR R, Knight S, Stojanovic J, Marks SD, et al
    Is Preemptive Kidney Transplantation Associated With Improved Outcomes when Compared to Non-preemptive Kidney Transplantation in Children? A Systematic Review and Meta-Analysis.
    Transpl Int. 2022;35:10315.
    PubMed     Abstract available


  13. SINGER J, Aouad LJ, Wyburn K, Gracey DM, et al
    The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant.
    Transpl Int. 2022;35:10078.
    PubMed     Abstract available


  14. HUEGLI S, Jaques DA, De Seigneux S, Haidar F, et al
    Anasarca, and Lymphadenopathy in a Kidney Transplant Patient: A Diagnostic and Therapeutic Challenge.
    Transpl Int. 2022;35:10148.
    PubMed    


  15. PAPALOIS V, Kotton CN, Budde K, Torre-Cisneros J, et al
    Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report.
    Transpl Int. 2022;35:10302.
    PubMed     Abstract available


  16. CASTRO FILHO JBS, Pompeo JC, Machado RB, Goncalves LFS, et al
    Delayed Graft Function Under the Microscope: Surveillance Biopsies in Kidney Transplantation.
    Transpl Int. 2022;35:10344.
    PubMed     Abstract available


  17. TASAKI M, Tateno H, Sato T, Tomioka A, et al
    A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Transpl Int. 2022;35:10248.
    PubMed     Abstract available


  18. DOBRIJEVIC ELK, Au EHK, Rogers NM, Clayton PA, et al
    Association Between Side of Living Kidney Donation and Post-Transplant Outcomes.
    Transpl Int. 2022;35:10117.
    PubMed     Abstract available


  19. TABBARA MM, Guerra G, Riella J, Abreu P, et al
    Creating a Single Inflow Orifice From Living Donor Kidney Allografts With Multiple Renal Arteries.
    Transpl Int. 2022;35:10212.
    PubMed     Abstract available


  20. MOREL A, Hoisnard L, Dudreuilh C, Moktefi A, et al
    Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
    Transpl Int. 2022;35:10228.
    PubMed     Abstract available


  21. SIMSIR M, Yildiz MG, Karatas M, Dalgic A, et al
    Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10198.
    PubMed     Abstract available


  22. VENTURA-AGUIAR P, Bayes-Genis B, Amor AJ, Cuatrecasas M, et al
    Patient Experience in Pancreas-Kidney Transplantation-A Methodological Approach Towards Innovation in an Established Program.
    Transpl Int. 2022;35:10223.
    PubMed     Abstract available


  23. YAHAV D, Rahamimov R, Mashraki T, Ben-Dor N, et al
    Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Transpl Int. 2022;35:10204.
    PubMed     Abstract available


  24. PHILLPOTT M, Daga S, Higgins R, Lowe D, et al
    Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation.
    Transpl Int. 2022;35:10128.
    PubMed     Abstract available


  25. KRISHNAN A, Wong G, Teixeira-Pinto A, Lim WH, et al
    Incidence and Outcomes of Early Cancers After Kidney Transplantation.
    Transpl Int. 2022;35:10024.
    PubMed     Abstract available


  26. DOHERTY DT, Athwal V, Moinuddin Z, Augustine T, et al
    Kidney Transplantation From Hepatitis-C Viraemic Donors:Considerations for Practice in the United Kingdom.
    Transpl Int. 2022;35:10277.
    PubMed     Abstract available


  27. HELANTERA I, Snyder J, Asberg A, Cruzado JM, et al
    Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.
    Transpl Int. 2022;35:10329.
    PubMed     Abstract available


  28. TANDUKAR S, Wu C, Hariharan S, Puttarajappa C, et al
    Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes.
    Transpl Int. 2022;35:10253.
    PubMed     Abstract available


  29. KLOMP SD, Meziyerh S, Vissers MFJM, Moes DJAR, et al
    Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism.
    Transpl Int. 2022;35:10269.
    PubMed     Abstract available


  30. PARK S, Yang SH, Kim J, Cho S, et al
    Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection.
    Transpl Int. 2022;35:10099.
    PubMed     Abstract available


  31. FARD A, Pearson R, Lathan R, Mark PB, et al
    Perfusate Composition and Duration of Ex-Vivo Normothermic Perfusion in Kidney Transplantation: A Systematic Review.
    Transpl Int. 2022;35:10236.
    PubMed     Abstract available


  32. BECKER JU, Seron D, Rabant M, Roufosse C, et al
    Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials.
    Transpl Int. 2022;35:10141.
    PubMed     Abstract available


  33. NAESENS M, Loupy A, Hilbrands L, Oberbauer R, et al
    Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.
    Transpl Int. 2022;35:10137.
    PubMed     Abstract available


  34. HILBRANDS L, Budde K, Bellini MI, Diekmann F, et al
    Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
    Transpl Int. 2022;35:10139.
    PubMed     Abstract available


  35. SERON D, Rabant M, Becker JU, Roufosse C, et al
    Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
    Transpl Int. 2022;35:10135.
    PubMed     Abstract available


  36. NAESENS M, Budde K, Hilbrands L, Oberbauer R, et al
    Surrogate Endpoints for Late Kidney Transplantation Failure.
    Transpl Int. 2022;35:10136.
    PubMed     Abstract available


  37. ROUFOSSE C, Becker JU, Rabant M, Seron D, et al
    Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
    Transpl Int. 2022;35:10140.
    PubMed     Abstract available


  38. BESTARD O, Thaunat O, Bellini MI, Bohmig GA, et al
    Alloimmune Risk Stratification for Kidney Transplant Rejection.
    Transpl Int. 2022;35:10138.
    PubMed     Abstract available


  39. TONG A, Oberbauer R, Bellini MI, Budde K, et al
    Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions.
    Transpl Int. 2022;35:10134.
    PubMed     Abstract available


  40. COOPER M, Schnitzler M, Nilubol C, Wang W, et al
    Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships With Renal Function and Graft Failure.
    Transpl Int. 2022;35:10422.
    PubMed     Abstract available


  41. VILLANEGO F, Vigara LA, Cazorla JM, Naranjo J, et al
    Evaluation of Expanded Criteria Donors Using the Kidney Donor Profile Index and the Preimplantation Renal Biopsy.
    Transpl Int. 2022;35:10056.
    PubMed     Abstract available


  42. KANT S, Brennan DC
    Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020-2021 Update.
    Transpl Int. 2022;35:10448.
    PubMed     Abstract available


  43. JUNG HY, Jeon Y, Huh KH, Park JB, et al
    Pretransplant and Posttransplant Alcohol Consumption and Outcomes in Kidney Transplantation: A Prospective Multicenter Cohort Study.
    Transpl Int. 2022;35:10243.
    PubMed     Abstract available


  44. GOPAL JP, McLean A, Crane J, Herbert P, et al
    Pancreas Transplantation in Black, Asian and Minority Ethnic Patients-Single Centre Experience in the UK.
    Transpl Int. 2022;35:10490.
    PubMed     Abstract available


  45. MOEINDARBARI T, Feizi M
    Kidneys for Sale: Empirical Evidence From Iran.
    Transpl Int. 2022;35:10178.
    PubMed     Abstract available


  46. RILEY S, Zhang Q, Tse WY, Connor A, et al
    Using Information Available at the Time of Donor Offer to Predict Kidney Transplant Survival Outcomes: A Systematic Review of Prediction Models.
    Transpl Int. 2022;35:10397.
    PubMed     Abstract available


  47. KILLIAN JT JR, Houp JA, Burkholder GA, Roman Soto SA, et al
    COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
    Transpl Int. 2022;35:10626.
    PubMed     Abstract available


  48. RANGEL EB, de Lucena DD, Aguiar-Brito I, de Andrade LGM, et al
    COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis.
    Transpl Int. 2022;35:10375.
    PubMed     Abstract available


  49. LANG JJ, Lombardi CV, James IA, Da Rocha-Afodu DB, et al
    A Payer's Perspective: A Comparison and Simulation of the Costs of Hemodialysis Versus Living Donor Kidney Transplant for Patients With End-Stage Renal Disease in Nigeria.
    Transpl Int. 2022;35:10662.
    PubMed    


  50. DELPIRE B, Van Loon E, Naesens M
    The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants.
    Transpl Int. 2022;35:10465.
    PubMed     Abstract available


  51. COZZI E, Alvarez M, Carmona M, Mahillo B, et al
    An Analysis by the European Committee on Organ Transplantation of the Council of Europe Outlining the International Landscape of Donors and Recipients Sex in Solid Organ Transplantation.
    Transpl Int. 2022;35:10322.
    PubMed     Abstract available


  52. BUDDE K, Rostaing L, Maggiore U, Piotti G, et al
    Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
    Transpl Int. 2022;35:10225.
    PubMed     Abstract available


  53. NAESENS M, Schneeberger S
    Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation.
    Transpl Int. 2022;35:10142.
    PubMed     Abstract available


  54. SIGURJONSDOTTIR VK, Purington N, Chaudhuri A, Zhang BM, et al
    Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients.
    Transpl Int. 2022;35:10158.
    PubMed     Abstract available


  55. SATTLER A, Thumfart J, Toth L, Schrezenmeier E, et al
    SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation.
    Transpl Int. 2022;35:10677.
    PubMed     Abstract available


  56. RAVAL AD, Ganz ML, Fraeman K, Lorden AL, et al
    Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study.
    Transpl Int. 2022;35:10528.
    PubMed     Abstract available


  57. MAMODE N, Bestard O, Claas F, Furian L, et al
    European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.
    Transpl Int. 2022;35:10511.
    PubMed     Abstract available


  58. URO-COSTE C, Atenza A, Heng AE, Rouzaire PO, et al
    Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients.
    Transpl Int. 2022;35:10681.
    PubMed    


  59. HALFON M, Stavart L, Venetz JP, Manuel O, et al
    Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
    Transpl Int. 2022;35:10716.
    PubMed    


  60. SHARIF A
    Deceased Donor Characteristics and Kidney Transplant Outcomes.
    Transpl Int. 2022;35:10482.
    PubMed     Abstract available


  61. SHIMADA S, Shamaa T, Ivanics T, Kitajima T, et al
    Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.
    Transpl Int. 2022;35:10489.
    PubMed     Abstract available


  62. JI M, Wang M, Hu W, Ibrahim M, et al
    Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.
    Transpl Int. 2022;35:10618.
    PubMed     Abstract available


  63. LEE KW, Sim J, Park SSW, Jeon J, et al
    Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation.
    Transpl Int. 2022;35:10714.
    PubMed     Abstract available


  64. PAPADIMITRIOU-OLIVGERIS M, Cipriano A, Guggisberg N, Kroemer M, et al
    Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
    Transpl Int. 2022;35:10721.
    PubMed     Abstract available


  65. JEHN U, Altuner U, Pavenstadt H, Reuter S, et al
    First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient.
    Transpl Int. 2022;35:10846.
    PubMed    


  66. JARRAR F, Tennankore KK, Vinson AJ
    Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation.
    Transpl Int. 2022;35:10656.
    PubMed     Abstract available


  67. SPAGGIARI M, Petrochenkov E, Patel H, Di Cocco P, et al
    Donor Size Doesn't Impact En Bloc Kidney Transplant Outcomes: A Single-Center Experience and Review of Literature.
    Transpl Int. 2022;35:10731.
    PubMed     Abstract available


  68. REIMANN AV, Nilsson J, Wuethrich RP, Mueller TF, et al
    Entering the Third Decade After Kidney Transplantation: Excellent Graft Function Refers to Superior Graft but Not Patient Survival.
    Transpl Int. 2022;35:10675.
    PubMed     Abstract available


  69. DE WEERD AE, Fatly ZA, Boer-Verschragen M, Kal-van Gestel JA, et al
    Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study.
    Transpl Int. 2022;35:10839.
    PubMed     Abstract available


  70. JI M, Wang M, Hu W, Ibrahim M, et al
    Corrigendum: Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.
    Transpl Int. 2022;35:10952.
    PubMed     Abstract available


  71. KOGA S, Yamanaga S, Hidaka Y, Tanaka K, et al
    Influence of Graft Ureter Length, a Donor-Related Factor, on Urinary Tract Infections After Living-Donor Kidney Transplantation: A Single-Center Analysis of 211 Cases.
    Transpl Int. 2022;35:10754.
    PubMed     Abstract available


    December 2021
  72. CHANDRA A, Malhotra KP, Rao NS, Singh AK, et al
    Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum.
    Transpl Int. 2021;34:2895-2896.
    PubMed     Abstract available


  73. KOENJER LM, Meinderts JR, van der Heijden OWH, Lely T, et al
    Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study.
    Transpl Int. 2021;34:2669-2679.
    PubMed     Abstract available


  74. DESHPANDE PP, Jariwala S, Martin L, Golestaneh L, et al
    Impact of technology-based interventions on linking potential kidney donors and transplant candidates: a scoping review.
    Transpl Int. 2021;34:2781-2793.
    PubMed     Abstract available


  75. THOMAS CP, Gupta S, Freese ME, Chouhan KK, et al
    Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation.
    Transpl Int. 2021;34:2696-2705.
    PubMed     Abstract available


  76. ROGERS R, Bodziak K, Cheema F, Chobanian M, et al
    Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres.
    Transpl Int. 2021;34:2680-2685.
    PubMed     Abstract available


  77. CETINER M, Paul A, Treckmann JW, Dittmann S, et al
    Small donors for small recipients - excellent growth and long-term function of single kidney grafts.
    Transpl Int. 2021;34:2735-2745.
    PubMed     Abstract available


  78. MONTERO N, Toapanta N, Pallares N, Crespo M, et al
    Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution.
    Transpl Int. 2021;34:2494-2506.
    PubMed     Abstract available


  79. CHANDRA A, Malhotra KP, Rao NS, Singh AK, et al
    Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum.
    Transpl Int. 2021;34:2910-2912.
    PubMed     Abstract available


  80. LIU JY, Zhang JM, Zhan HS, Sun LY, et al
    EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review.
    Transpl Int. 2021;34:2483-2493.
    PubMed     Abstract available


    November 2021
  81. ASGARISABET P, Rajan SS, Lee M, Morgan RO, et al
    The Beneficial Effect of Providing Kidney Transplantation Information on Transplantation Status Differs Between For-profit and Non-profit Dialysis Centers.
    Transpl Int. 2021 Nov 2. doi: 10.1111/tri.14151.
    PubMed     Abstract available


  82. PEREZ-BLANCO A, Lopez-Fraga M, Forsythe J, Pires Silva AM, et al
    Access of non-residents to transplantation of deceased donor organs: practices and strategies in the European setting.
    Transpl Int. 2021;34:2112-2121.
    PubMed     Abstract available


  83. PATRAS M, Decullier E, Lebbe C, Delyon J, et al
    Outcome of pretransplant melanoma after solid organ transplantation: an observational study.
    Transpl Int. 2021;34:2154-2165.
    PubMed     Abstract available


  84. GANDHI NV, Murad DN, Nguyen DT, Graviss EA, et al
    Hypertension and renal outcomes in normotensive kidney donors with multiple renal arteries.
    Transpl Int. 2021;34:2382-2393.
    PubMed     Abstract available


  85. REDEKER S, Massey EK, Boonstra C, van Busschbach JJ, et al
    Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects.
    Transpl Int. 2021;34:2317-2328.
    PubMed     Abstract available


  86. AUGUSTO JF, Gatault P, Sayegh J, Garnier AS, et al
    Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post-transplant lymphoproliferative diseases: three successive cases.
    Transpl Int. 2021;34:2415-2417.
    PubMed     Abstract available


  87. KOWALEWSKA J, El Moudden I, Perkowska-Ptasinska A, Kapp ME, et al
    Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy.
    Transpl Int. 2021;34:2286-2296.
    PubMed     Abstract available


    October 2021
  88. DE WEERD AE, van den Brand JAJG, Bouwsma H, de Vries APJ, et al
    ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis.
    Transpl Int. 2021 Oct 22. doi: 10.1111/tri.14145.
    PubMed     Abstract available


  89. AVNI-NACHMAN S, Yahav D, Nesher E, Rozen-Zvi B, et al
    Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation.
    Transpl Int. 2021 Oct 20. doi: 10.1111/tri.14144.
    PubMed     Abstract available


  90. PEREZ-SAEZ MJ, Juega J, Zapatero A, Comas J, et al
    Kidney transplant outcomes in elderly recipients with controlled donation after circulatory death or donation after brain death donors: A registry cohort study.
    Transpl Int. 2021 Oct 19. doi: 10.1111/tri.14141.
    PubMed     Abstract available


  91. PARAJULI S, Kaufman DB, Djamali A, Welch BM, et al
    Association of Human Leukocyte Antigen Mismatches Between Donor-recipient And Donor-donor in Pancreas after Kidney Transplant Recipients.
    Transpl Int. 2021 Oct 13. doi: 10.1111/tri.14138.
    PubMed     Abstract available


  92. JUNG HY, Jeon Y, Huh KH, Park JB, et al
    The Impact of Recipient and Donor Smoking in Living-Donor Kidney Transplantation: A Prospective Multicenter Cohort Study.
    Transpl Int. 2021 Oct 12. doi: 10.1111/tri.14137.
    PubMed     Abstract available


  93. LIM JH, Jeon Y, Lee SH, Lee YH, et al
    Declining trend of preemptive kidney transplantation and impact of pretransplant dialysis: a Korean nationwide prospective cohort study.
    Transpl Int. 2021 Oct 11. doi: 10.1111/tri.14135.
    PubMed     Abstract available


  94. LAI C, Yee SY, Ying T, Chadban S, et al
    Biomarkers as diagnostic tests for delayed graft function in kidney transplantation.
    Transpl Int. 2021 Oct 9. doi: 10.1111/tri.14132.
    PubMed     Abstract available


  95. TEGZESS E, Gomes Neto AW, Pol RA, de Boer SE, et al
    Comparative survival of elderly renal transplant recipients with a living donor versus a deceased donor: A retrospective single center observational study.
    Transpl Int. 2021 Oct 9. doi: 10.1111/tri.14130.
    PubMed     Abstract available


  96. COEMANS M, Senev A, Van Loon E, Lerut E, et al
    The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies.
    Transpl Int. 2021;34:1824-1836.
    PubMed     Abstract available


  97. ANDRES AM, Talayero P, Alcolea Sanchez A, Sanchez Galan A, et al
    Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long-term benefits.
    Transpl Int. 2021;34:1895-1907.
    PubMed     Abstract available


    September 2021
  98. VILLENEUVE C, Rerolle JP, Couzi L, Westeel PF, et al
    Therapeutic education as a tool to improve patient-reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study.
    Transpl Int. 2021 Sep 29. doi: 10.1111/tri.14127.
    PubMed     Abstract available


  99. RUENROENGBUN N, Numthavaja P, Sapankaew T, Chaiyakittisopon K, et al
    "Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta-analysis".
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14122.
    PubMed     Abstract available


  100. WEHMEIER C, Amico P, Sidler D, Wirthmuller U, et al
    Pre-transplant donor-specific HLA antibodies and risk for poor first year renal transplant outcomes - Results from the Swiss Transplant Cohort Study.
    Transpl Int. 2021 Sep 24. doi: 10.1111/tri.14119.
    PubMed     Abstract available


  101. SCHMIDT-LAUBER C, Spoden M, Huber TB, Gunster C, et al
    Increased Rejection rates in kidney transplantations during the COVID-19 Pandemic.
    Transpl Int. 2021 Sep 23. doi: 10.1111/tri.14114.
    PubMed     Abstract available


  102. DOUWES RM, Vinke JSJ, Gomes-Neto AW, Ayerdem G, et al
    Type of Proton-Pump Inhibitor and Risk of Iron Deficiency in Kidney Transplant Recipients - Results from the TransplantLines Biobank and Cohort Study.
    Transpl Int. 2021 Sep 14. doi: 10.1111/tri.14110.
    PubMed     Abstract available


  103. RUBIN RA, Mehta M, Rossi A, Joeslon D, et al
    Endoscopic Ultrasound Guided Portal-systemic Pressure Gradient Measurement to Determine Candidacy for Kidney Transplant Alone vs. Combined Liver Kidney Transplant in Patients with Advanced Fibrosis or Cirrhosis.
    Transpl Int. 2021 Sep 12. doi: 10.1111/tri.14105.
    PubMed     Abstract available


  104. VAN ZANTEN R, de Weerd A, Betjes M, Boer-Verschragen M, et al
    Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial.
    Transpl Int. 2021;34:1703-1711.
    PubMed     Abstract available


  105. BLAZQUEZ-NAVARRO A, Dang-Heine C, Wehler P, Roch T, et al
    Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study.
    Transpl Int. 2021;34:1680-1688.
    PubMed     Abstract available


  106. MAYER KA, Doberer K, Tillgren A, Viard T, et al
    Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Transpl Int. 2021;34:1689-1702.
    PubMed     Abstract available


  107. VAN LEEUWEN LL, Spraakman NA, Brat A, Huang H, et al
    Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1-year outcome.
    Transpl Int. 2021;34:1618-1629.
    PubMed     Abstract available


    August 2021
  108. SAMPAIO MS, Lawrence Lum E, Homkrailas P, Gritsch HA, et al
    Outcomes of Small Pediatric Donor Kidney Transplants According to Donor Weight.
    Transpl Int. 2021 Aug 24. doi: 10.1111/tri.14026.
    PubMed     Abstract available


  109. OUAHMI H, Moceri P, Zorzi K, Albano L, et al
    Outcomes of kidney transplantation in patients with prosthetic heart valves.
    Transpl Int. 2021 Aug 23. doi: 10.1111/tri.14008.
    PubMed     Abstract available


  110. RIJKSE E, Qi H, Babakry S, Bijdevaate DC, et al
    To screen or not to screen? The development of a prediction model for aorto-iliac stenosis in kidney transplant candidates.
    Transpl Int. 2021 Aug 20. doi: 10.1111/tri.14013.
    PubMed     Abstract available


  111. MEKRAKSAKIT P, Boonpheng B, Leelaviwat N, Duangkham S, et al
    Risk Factors and Outcomes of Post-Transplant Erythrocytosis among Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14016.
    PubMed     Abstract available


  112. GHIDINI F, De Corti F, Fascetti Leon F, Vidal E, et al
    Extraperitoneal kidney transplantation: a comparison between children weighting 15 kg. experience of a single institution.
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14015.
    PubMed     Abstract available


  113. ERLANDSSON H, Qureshi AR, Scholz T, Lundgren T, et al
    Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden - a decade of follow-up.
    Transpl Int. 2021 Aug 4. doi: 10.1111/tri.14004.
    PubMed     Abstract available


  114. LOMBARDI Y, Hiesse C, Ridel C, Touzot M, et al
    From combined heart-kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy.
    Transpl Int. 2021;34:1573-1575.
    PubMed     Abstract available


  115. AL AMMARY F, Yu S, Muzaale AD, Segev DL, et al
    Long-term kidney function and survival in recipients of allografts from living kidney donors with hypertension: a national cohort study.
    Transpl Int. 2021;34:1530-1541.
    PubMed     Abstract available


  116. LUQUE Y, Jamme M, Aubert O, Roux A, et al
    A kidney discard decision strategy based on zero-time histology analysis could lead to an unjustified increase in the organ turndown rate among ECD.
    Transpl Int. 2021;34:1506-1516.
    PubMed     Abstract available


  117. KLAGER J, Eskandary F, Bohmig GA, Kozakowski N, et al
    Renal allograft DARCness in subclinical acute and chronic active ABMR.
    Transpl Int. 2021;34:1494-1505.
    PubMed     Abstract available


    July 2021
  118. MARTIN K, Cantwell L, Barraclough KA, Lian M, et al
    Prolonged immunosuppression does not improve risk of sensitisation or likelihood of re-transplantation after kidney transplant graft failure.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13998.
    PubMed     Abstract available


  119. GOKMEN R, Cronin A, Brown W, Cass S, et al
    Kidney transplantation and patients who decline SARS-CoV-2 vaccination: an ethical framework.
    Transpl Int. 2021 Jul 19. doi: 10.1111/tri.13979.
    PubMed     Abstract available


  120. INGOLD L, Halter J, Martinez M, Amico P, et al
    Short- and long-term impact of neutropenia within the first year after kidney transplantation.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13976.
    PubMed     Abstract available


  121. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    PubMed     Abstract available


  122. THOMAS R, Consolo H, Oniscu GC
    Have we reached the limits in altruistic kidney donation?
    Transpl Int. 2021;34:1187-1197.
    PubMed     Abstract available


  123. HUSAIN SA, King KL, Coley S, Natarajan K, et al
    Association between procurement biopsy findings and deceased donor kidney outcomes: a paired kidney analysis.
    Transpl Int. 2021;34:1239-1250.
    PubMed     Abstract available


    June 2021
  124. HOMKRAILAS P, Bunnapradist S
    Association between ethnicity and kidney transplant waitlist outcomes beyond estimated post transplant survival score.
    Transpl Int. 2021 Jun 30. doi: 10.1111/tri.13965.
    PubMed     Abstract available


  125. THEODORAKOPOULOU MP, Boutou AK, Pella E, Alexandrou ME, et al
    Cardiorespiratory fitness in kidney transplant recipients compared to patients with kidney failure: a systematic review and meta-analysis.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13961.
    PubMed     Abstract available


  126. JOACHIM E, Jorgenson MR, Astor BC, Smith JA, et al
    Pre-transplant bariatric surgery is not associated with an increased risk of infection after kidney transplant.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13958.
    PubMed     Abstract available


  127. MUHLBACHER J, Schorgenhofer C, Doberer K, Durr M, et al
    Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
    Transpl Int. 2021 Jun 21. doi: 10.1111/tri.13954.
    PubMed     Abstract available


  128. HELLEMANS R, Pengel L, Choquet S, Maggiore U, et al
    Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): overview of the available evidence and guidance for shared decision making.
    Transpl Int. 2021 Jun 19. doi: 10.1111/tri.13952.
    PubMed     Abstract available


  129. HUUSKES BM, Scholes-Robertson N, Guha C, Baumgart A, et al
    Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic.
    Transpl Int. 2021 Jun 11. doi: 10.1111/tri.13934.
    PubMed     Abstract available


  130. PANTHOFER AM, Lyu B, Astor BC, Singh T, et al
    Post-Kidney Transplant Serum Magnesium Exhibits a U-Shaped Association with Subsequent Mortality: An Observational Cohort Study.
    Transpl Int. 2021 Jun 3. doi: 10.1111/tri.13932.
    PubMed     Abstract available


  131. GAVRIILIDIS P, O' Callaghan JM, Hunter J, Fernando T, et al
    Allograft Nephrectomy versus Non-Allograft Nephrectomy after Failed Renal Transplantation: A Systematic Review by Updated Meta-Analysis.
    Transpl Int. 2021 Jun 1. doi: 10.1111/tri.13901.
    PubMed     Abstract available


  132. BESTARD O, Couzi L, Crespo M, Kessaris N, et al
    Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group.
    Transpl Int. 2021;34:1005-1018.
    PubMed     Abstract available


  133. GAILLARD F, Jacquemont L, Lazareth H, Albano L, et al
    Living kidney donor evaluation for all candidates with normal estimated GFR for age.
    Transpl Int. 2021;34:1123-1133.
    PubMed     Abstract available


    May 2021
  134. JIA H, Huang F, Zhang X, Cheng J, et al
    Early perioperative fluid overload is associated with adverse outcomes in deceased donor kidney transplantation.
    Transpl Int. 2021 May 30. doi: 10.1111/tri.13926.
    PubMed     Abstract available


  135. LOMBARDI Y, Hiesse C, Ridel C, Touzot M, et al
    From combined heart-kidney to kidney transplantation program: What nephrologists should know about dilated cardiomyopathy.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13922.
    PubMed     Abstract available


  136. ROBERTSEN I, Asberg A, Jenssen TG, Gence B, et al
    Increased systemic exposure of once daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementation.
    Transpl Int. 2021 May 15. doi: 10.1111/tri.13917.
    PubMed     Abstract available


  137. MAGGIORE U
    Incomplete Recovery from COVID-19 associated Acute Kidney Injury (AKI) in Kidney Transplant Recipients: Prior Graft Injury Matters The Most.
    Transpl Int. 2021 May 7. doi: 10.1111/tri.13896.
    PubMed     Abstract available


  138. NEYENS T
    Did an effect of kidney transplantation on COVID-19 mortality go unnoticed due to selection bias?
    Transpl Int. 2021;34:773-775.
    PubMed    


  139. OSMANODJA B, Mayrdorfer M, Halleck F, Choi M, et al
    Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population.
    Transpl Int. 2021;34:769-771.
    PubMed    


  140. HUGO C, Vehreschild J, Stecher M
    Response to Invited Commentary "Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population".
    Transpl Int. 2021;34:771-773.
    PubMed    


  141. HRUBA P, Madill-Thomsen K, Mackova M, Maluskova J, et al
    Three-month course of intragraft transcriptional changes in kidney allografts with early histological minimal injury - a cohort study.
    Transpl Int. 2021;34:974-985.
    PubMed     Abstract available


    April 2021
  142. FERREIRA AC, Mendes M, Silva C, Cotovio P, et al
    Bone densitometry versus bone histomorphometry in renal transplanted patients: A cross-sectional study.
    Transpl Int. 2021 Apr 28. doi: 10.1111/tri.13888.
    PubMed     Abstract available


  143. BACH C, Knaup KX, Herrmann M, Krumbiegel M, et al
    A non-invasive diagnostic approach to retrospective donor HLA-typing in kidney transplant patients using urine.
    Transpl Int. 2021 Apr 27. doi: 10.1111/tri.13893.
    PubMed     Abstract available


  144. FU Y, Cao Y, Wang H, Zhao J, et al
    Metabolic Outcomes and Renal Function after Simultaneous Kidney/Pancreas Transplantation compared with Kidney Transplantation Alone for Type 2 Diabetes Mellitus patients.
    Transpl Int. 2021 Apr 25. doi: 10.1111/tri.13892.
    PubMed     Abstract available


  145. OBI Y, Ichimaru N, Sakaguchi Y, Iwadoh K, et al
    Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients (CANDLE-KIT): a Multicenter, 2x2 Factorial, Open-label, Randomized Clinical Trial.
    Transpl Int. 2021 Apr 22. doi: 10.1111/tri.13885.
    PubMed     Abstract available


  146. IRENE BELLINI M, D'Andrea V, Rubulotta F, Spennati V, et al
    Postoperative delirium in kidney transplant patients.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13890.
    PubMed     Abstract available


  147. BAJPAI D, Deb S, Bose S, Gandhi C, et al
    Recovery of kidney function after AKI due to COVID-19 in kidney transplant recipients.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13886.
    PubMed     Abstract available


  148. NAEF B, Nilsson J, Wuethrich RP, Mueller TF, et al
    Intravenous Immunoglobulins Do Not Prove Beneficial to Reduce Alloimmunity among Kidney Transplant Recipients with BKV-Associated Nephropathy.
    Transpl Int. 2021 Apr 19. doi: 10.1111/tri.13882.
    PubMed     Abstract available


  149. VAN DELDEN C
    Is transplantation per se a risk factor for worse outcome of SARS-CoV-2 infection in kidney transplant recipients?
    Transpl Int. 2021 Apr 16. doi: 10.1111/tri.13879.
    PubMed     Abstract available


  150. TSUJITA M, Azhar A, Joglekar K, Talwar M, et al
    The Incidence of Hepatitis B Coinfection after Deceased-Donor Kidney Transplantation from Hepatitis C Infected Donors to Hepatitis C Negative Recipients.
    Transpl Int. 2021 Apr 8. doi: 10.1111/tri.13877.
    PubMed     Abstract available


  151. MESSNER F, Leemkuil M, Yu Y, Massie AB, et al
    Recipient age and outcome after pancreas transplantation: a retrospective dual-center analysis.
    Transpl Int. 2021;34:657-668.
    PubMed     Abstract available


  152. SCHREZENMEIER E, Lehner LJ, Merkel M, Mayrdorfer M, et al
    What happens after graft loss? A large, long-term, single-center observation.
    Transpl Int. 2021;34:732-742.
    PubMed     Abstract available


  153. TIMOFEEVA OA, Choe J, Alsammak M, Yoon EJ, et al
    Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective study.
    Transpl Int. 2021;34:700-708.
    PubMed     Abstract available


    March 2021
  154. EKWENNA O, Lang J, Thomas I
    APOL1 screening of potential living kidney donors in resource-limited countries: an initial experience in Antigua & Barbuda and Nigeria.
    Transpl Int. 2021;34:590-592.
    PubMed    


  155. PUNJALA SR, Adamjee Q, Silas L, Gokmen R, et al
    Weight trends in living kidney donors suggest predonation counselling alone lacks a sustainable effect on weight loss: a single centre cohort study.
    Transpl Int. 2021;34:514-524.
    PubMed     Abstract available


  156. AKIN EB, Soykan Barlas I, Dayangac M
    Hand-assisted retroperitoneoscopic donor nephrectomy offers more liberal use of right kidneys: lessons learned from 565 cases - a retrospective single-center study.
    Transpl Int. 2021;34:445-454.
    PubMed     Abstract available


  157. PFREPPER C, Herber A, Weimann A, Siegemund R, et al
    Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation.
    Transpl Int. 2021;34:423-435.
    PubMed     Abstract available


    February 2021
  158. HOSGOOD SA, Hoff M, Nicholson ML
    Treatment of transplant kidneys during machine perfusion.
    Transpl Int. 2021;34:224-232.
    PubMed     Abstract available


    January 2021
  159. HECKING M, Sharif A, Eller K, Jenssen T, et al
    Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
    Transpl Int. 2021;34:27-48.
    PubMed     Abstract available


  160. RO H, Jeong JC, Kong JM, Min JW, et al
    The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data.
    Transpl Int. 2021;34:163-174.
    PubMed     Abstract available


  161. GREGORINI M, Ticozzelli E, Abelli M, Grignano MA, et al
    Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death.
    Transpl Int. 2022;35:10179.
    PubMed     Abstract available


  162. RODRIGUEZ-GONCER I, Ruiz-Ruigomez M, Lopez-Medrano F, Trujillo H, et al
    Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.
    Transpl Int. 2022;35:10273.
    PubMed     Abstract available


  163. NETO HM, Tedesco Silva Junior H, Pestana JM, Foresto RD, et al
    Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients.
    Transpl Int. 2022;35:10213.
    PubMed     Abstract available


  164. BEERLI N, Denhaerynck K, Binet I, Dahdal S, et al
    Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study.
    Transpl Int. 2022;35:10076.
    PubMed     Abstract available


  165. MORATH C, Hayek SS, Dohler B, Nusshag C, et al
    Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10071.
    PubMed     Abstract available


  166. PIRKLBAUER M, Berger M, Boban MD, Tiefenthaler M, et al
    The Tangential Extraperitoneal Retrorenal Approach in Kidney Transplant Biopsy: An Observational Study to Assess Complication and Adequacy Rates.
    Transpl Int. 2022;35:10068.
    PubMed     Abstract available


  167. SCHIMPF J, Sprenger-Mahr H, Davidovic T, Lhotta K, et al
    Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients.
    Transpl Int. 2022;35:10060.
    PubMed    


  168. NIMMO A, Graham-Brown M, Griffin S, Sharif A, et al
    Pre-Kidney Transplant Screening for Coronary Artery Disease: Current Practice in the United Kingdom.
    Transpl Int. 2022;35:10039.
    PubMed    


  169. HALLER MC, Kaiser RA, Langthaler S, Brandstetter C, et al
    Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Transpl Int. 2022;35:10026.
    PubMed    


  170. MAASSEN H, Leuvenink HGD, van Goor H, Sanders JF, et al
    Prolonged Organ Extraction Time Negatively Impacts Kidney Transplantation Outcome.
    Transpl Int. 2022;35:10186.
    PubMed     Abstract available


    November 2020
  171. LIM WH, Wong G
    Complex kidney donors: should we stretch our limits?
    Transpl Int. 2020;33:1390-1392.
    PubMed    


  172. GRINYO JM
    Renal allograft performance in immigrant transplant recipients.
    Transpl Int. 2020;33:1387-1389.
    PubMed    


    October 2020
  173. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
    De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
    Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
    PubMed     Abstract available


  174. DUDREUILH C, Dorling A
    Effect of rituximab on anti-donor T-cell responses.
    Transpl Int. 2020;33:1322-1323.
    PubMed    


  175. THOMPSON ER, Wilson CH
    Time to reflect, time to move on.
    Transpl Int. 2020;33:1185-1186.
    PubMed    


    July 2020
  176. SHARIF A, Lavee J, Baquero A, Fiatarone Singh M, et al
    Reply to Chen et al.
    Transpl Int. 2020;33:819-820.
    PubMed    


    January 2020
  177. SHARIF A
    Should donor body mass index influence kidney utilization by transplant centers?
    Transpl Int. 2020;33:56-58.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: